Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of helium inhalation on immune function in healthy volunteers
2009-010078-39Phase 2Completed
- Sponsor
- Academic Medical Center
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of heliox21, sponsored by Academic Medical Center. Primary endpoint: Proinflammatory cytokine production after ex vivo stimulation. Started Jan 2009; status: completed.
02
Drugs
heliox21
Beyond the preview
Go deeper on 2009-010078-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010078-39.